SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) — Lycia Therapeutics, Inc., a biotechnology company developing lysosomal targeting chimera (LYTAC)-based protein degradation therapies to eliminate disease at its…Read More

You might also be interested in reading Crypto skeptic Brad Sherman: federal financial regulators ‘sound like Sam Bankman-Fried’.